본문 바로가기
KERD
논문KCI 등재

호산구성 중이염에서 Dupilumab의 치료 1예

Dupilumab in the Treatment of Eosinophilic Otitis Media: A Case Report

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류이비인후과학

초록

Eosinophilic otitis media (EOM) differs from classic chronic otitis media as it is a refractorydisease with the accumulation of eosinophils in thick mucinous middle ear effusion and mu-cosa. A 66-year-old male with a history of asthma, chronic sinusitis with polyposis, nasal pol-yposis, and multiple sets of ventilation tubes was presented to our center for the managementof hearing loss and otorrhea. He had a history of consistent otorrhea and hearing loss evenwith the ventilation tube insertions and medical treatment. Both systemic and intratympanicsteroid was administered, but the effect was insignificant and other systemic adverse effectsoccurred. Finally, the otologic symptoms including hearing loss and otorrhea improved afterbeing given a Dupilumab injection. This case report discusses Dupilumab treatment resultingin remission in a patient suffering from refractory EOM.

Abstract

Eosinophilic otitis media (EOM) differs from classic chronic otitis media as it is a refractorydisease with the accumulation of eosinophils in thick mucinous middle ear effusion and mu-cosa. A 66-year-old male with a history of asthma, chronic sinusitis with polyposis, nasal pol-yposis, and multiple sets of ventilation tubes was presented to our center for the managementof hearing loss and otorrhea. He had a history of consistent otorrhea and hearing loss evenwith the ventilation tube insertions and medical treatment. Both systemic and intratympanicsteroid was administered, but the effect was insignificant and other systemic adverse effectsoccurred. Finally, the otologic symptoms including hearing loss and otorrhea improved afterbeing given a Dupilumab injection. This case report discusses Dupilumab treatment resultingin remission in a patient suffering from refractory EOM.

참고문헌 (15)

  1. Iino Y, "Eosinophilic otitis media; state-of-the-art diagnosis and treatment", Auris Nasus Larynx, 50(4), pp.479~489 (2023)
  2. Kanazawa H, "New insights into eosinophilic otitis media", Curr Allergy Asthma Rep, 15(12), pp.76~ (2015)
  3. Iino Y, "Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease", Auris Nasus Larynx, 38(4), pp.456~461 (2011)
  4. De Corso E, "Efficacy of biologics on refractory eosinophilic otitis media associated with bronchial asthma or severe uncontrolled CRSwNP", J Clin Med, 11(4), pp.926~ (2022)
  5. Chen T, "Diagnosis and management of eosinophilic otitis media : A systematic review", Acta Otolaryngol, 141(6), pp.579~587 (2021)
  6. Ortega H, "Effects of systemic corticosteroids on blood eosinophil counts in asthma : Real-world data", J Asthma, 56(8), pp.808~815 (2019)
  7. Won TB, "Treatment outcomes and predictors for systemic steroids in nasal polyposis", Acta Otolaryngol, 132(Suppl 1), pp.S82~S87 (2012)
  8. Bachert C, "EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps(CRSwNP)and biologics : Definitions and management", J Allergy Clin Immunol, 147(1), pp.29~36 (2021)
  9. Grose E, "Clinical outcomes of dupilumab therapy in chronic rhinosinusitis with nasal polyps in a Canadian tertiary care rhinology practice", Allergy Asthma Clin Immunol, 19(1), pp.26~ (2023)
  10. Jendoubi F, "Longer dupilumab dosing intervals in adult patients with atopic dermatitis : Experience from a French multicentre retrospective cohort study", Br J Dermatol, 187(4), pp.602~603 (2022)
  11. De Corso E, "Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps(CRSwNP) : A multicentric observational phase IV real-life study(DUPIREAL)", Allergy, 78(10), pp.2669~2683 (2023)
  12. Iino Y, "Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma", Auris Nasus Larynx, 48(3), pp.353~360 (2021)
  13. van der Lans RJL, "Complete remission of severe eosinophilic otitis media with dupilumab : A case report", Laryngoscope, 131(12), pp.2649~2651 (2021)
  14. Nakashima D, "Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis", Allergol Int, 72(4), pp.557~563 (2023)
  15. Kikuchi S, "A case of eosinophilic otitis media successfully treated by tympanoplasty with use of dupilumab", Otolaryngol Case Rep, 21, pp.100381~ (2021)

관련 논문AI추천

이 간행물의 다른 논문 (8건)